CLARIVEST ASSET MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
CLARIVEST ASSET MANAGEMENT LLC portfolio value:
$1.24M
portfolio value
CLARIVEST ASSET MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -23.69% | -3.63K shares | -252K | $106.21 | 11.72K |
| Q2 2022 | share | Decrease | -20.66% | -4K shares | -318K | $97.48 | 15.36K |
| Q1 2022 | share | 0.00% | 0 shares | 166K | $93.75 | 19.36K | |
| Q4 2021 | share | Decrease | -8.94% | -1.9K shares | -390K | $84.63 | 19.36K |
| Q3 2021 | share | Decrease | -2.30% | -500 shares | -78K | $95.91 | 21.26K |
| Q2 2021 | share | 0.00% | 0 shares | 1K | $97.32 | 21.76K | |
| Q1 2021 | share | Decrease | -0.91% | -200 shares | 11K | $97.25 | 21.76K |
| Q4 2020 | share | Decrease | -0.90% | -200 shares | -26K | $95.85 | 21.96K |
| Q3 2020 | share | Decrease | -2.03% | -460 shares | -629K | $96.16 | 22.16K |
| Q2 2020 | share | Increase | +113.40% | 12.02K shares | 1.84M | $122 | 22.62K |
| Q1 2020 | share | Increase | 0.00% | 10.6K shares | 918K | $86.55 | 10.6K |
| Q2 2018 | share | Decrease | -100.00% | -14.01K shares | -1.16M | $98.24 | 0 |
| Q1 2018 | share | Increase | +0.72% | 100 shares | 84K | $82.93 | 14.01K |
| Q4 2017 | share | Decrease | -52.53% | -15.39K shares | -717K | $77.59 | 13.91K |
| Q3 2017 | share | 0.00% | 0 shares | 448K | $61.28 | 29.31K | |
| Q2 2017 | share | Decrease | -0.07% | -20 shares | 77K | $46 | 29.31K |
| Q1 2017 | share | 0.00% | 0 shares | 136K | $43.3 | 29.33K | |
| Q4 2016 | share | Decrease | -0.10% | -29 shares | -351K | $38.7 | 29.33K |
| Q3 2016 | share | Decrease | -26.04% | -10.33K shares | -318K | $50.64 | 29.36K |
| Q2 2016 | share | Increase | +15.41% | 5.3K shares | 443K | $45.45 | 39.70K |
| Q1 2016 | share | Increase | +4.03% | 1.33K shares | -510K | $39.55 | 34.40K |